QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Companion Diagnostics

News   Jun 10, 2013

 
QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Companion Diagnostics
 
 
 

RELATED ARTICLES

Genetic Variations in the Lungs Identify COPD Risk

News

Developmental genetic variations in the anatomy of the lung could indicate people at risk of COPD later in life, a study suggests.

READ MORE

"Cell Quake Elastography" Maps Elasticity of Cell Components

News

In somewhat the same way that seismologists use the vibrations of planet Earth to characterize its deep structure, scientists have discovered a way to use vibrations within cells to identify their mechanical properties.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE